Aim: To determine infant survival and neonatal outcome after fetoscopic laser treatment of twin-to-twin transfusion syndrome (TTTS). Results: In 53/71(75 % ) laser-treated TTTS cases, at least one twin was liveborn and in 42/71(59 % ) cases at least one twin survived infancy. Fetal survival did not differ between donors [41/71(58 % )] and recipients [46/71(65 % ), P = 0.36]. Among liveborns, infant survival was 29/41(71 % ) in donors and 36/46(78 % ) in recipients (P = 0.12). Infant survival did not correlate to maternal characteristics (age, BMI, smoking or parity), gestational age at treatment or severity of TTTS (Quintero stage). No TTTS infant born before 25 weeks of gestation survived the fi rst week. Among the 87 infant survivors, 26 (30%) had an Apgar score < 7 at 5 min, 47 (54%) developed respiratory distress syndrome, 10 (11 % ) showed signs of severe brain damage, nine (10 % ) renal failure, eight (9 % ) bronchopulmonary dysplasia, and fi ve (6 % ) infants developed retinopathy of prematurity ≥ stage 3. There was no signifi cant difference in neonatal morbidity between recipients and donors. Conclusions: Fetal survival after laser treatment was comparable to that reported by other international centers. There was no signifi cant difference in survival or neonatal morbidity between donors and recipients. Major neonatal morbidity was common, and combined with extremely preterm delivery the prognosis of TTTS is poor.
Introduction
Twin pregnancies represent 1 -3 % of all births. In Sweden the incidence during the past decade is reported to have been 1.5 % [33] . Among twin gestations, monochorionic pregnancies carry a higher risk for complications as compared to dichorionic pregnancies. One of the most severe complications is twin-to-twin transfusion syndrome (TTTS), occurring in 9 % of all monochorionic pregnancies [21] . TTTS is usually evident in the second trimester as a pronounced discordance in amniotic fl uid volume [7] .
In TTTS, the donor fetus transfuses blood through deep arteriovenous anastomoses to the recipient twin. This results in a chronic, unbalanced shift in volume of blood, making the donor hypovolemic, oliguric, hypotensive and subsequently growth retarded, whereas the recipient becomes hypervolemic, polyuric and hypertensive [25] , with a high risk of developing cardiac dysfunction [4, 10, 19] . Assessment of the severity of TTTS during gestation is achieved with ultrasound and Doppler technique, and staging according to Quintero ' s fi ve stages is a well-established method [30] .
Untreated, the overall fetal and neonatal mortality rate in TTTS has been reported as high as 80 % [7] . Ever since the late 1980s, when Dr. Julian De Lia (Utah, USA) pioneered the use of selective laser coagulation to abolish the deep placental anastomoses in the common twin placenta [5] , several centers for fetal medicine throughout the world have adopted fetoscopic laser occlusive coagulation (FLOC) as an established therapeutic method for treating TTTS. Although FLOC has reduced mortality [32] , there are several unresolved issues. The effects of FLOC in relation to gestational age at diagnosis or stage of disease are still unclear [31, 32, 34] . While FLOC has been shown to reduce fetal demise in TTTS, the effect of superimposed neonatal morbidity after preterm birth on survival among liveborn infants has been poorly reported.
The objective of this study was to perform a thorough assessment of survival -from start of fetal treatment to 1 year of postnatal age -in the fi rst Swedish cohort of TTTS fetuses treated with FLOC. Secondary outcomes included neonatal anthropometry and morbidity. All outcomes were stratifi ed on donor and recipient twins. Any contribution to outcome from different perinatal risk factors, including gestational age at treatment, was evaluated.
Methods

Subjects
This is an observational cohort study of fetal and infant survival and morbidity after FLOC for TTTS. The setting is a tertiary center for fetal medicine in Sweden. Between October 2001 and July 2010, 123 pregnant women were referred to the center for fetal medicine at Karolinska University Hospital in Huddinge for consideration of fetoscopic laser coagulation treatment due to suspected TTTS. Obligatory signs of TTTS included monochorionic twin pregnancy complicated by oligohydramnios of one fetus and polyhydramnios of the other fetus. Among the referrals there were two triplet pregnancies. In 14 of the referrals, TTTS diagnosis could not be confi rmed. All confi rmed TTTS pregnancies were graded using the Quintero staging system [30] : stage I: polyhydramnios with a deepest vertical pocket ≥ 8 cm in recipient ' s sac and oligohydramnios with a deepest vertical pocket ≤ 2 cm in donor ' s sac; stage II: as in I, but no visible bladder in the donor; stage III: as in II and abnormal Doppler fl ow in umbilical artery, vein or ductus venosus; stage IV: as in III and hydrops of either twin; stage V: fetal demise of one or both twins. Laser treatment was considered indicated if the Quintero stage was II -IV and gestational duration was ≤ 26 weeks (n = 71; stage II = 34, III = 31 and IV = 6). In addition, two women with Quintero stage I were treated due to pronounced maternal discomfort from excessive polyhydramnios. Overall, 73 pregnancies with confi rmed TTTS were treated with FLOC. Twenty-six treated patients were referred from hospitals within the Stockholm region (37 % ) and 42 (59 % ) from other regions of Sweden. Three women (4 % ) came from other Nordic countries (Norway, n = 2, Finland, n = 1). The characteristics of these women did not differ from domestic cases and were therefore included in the analyses. During the study period, women living in the southern-most part of Sweden with TTTS pregnancies and in need of FLOC were referred to Denmark or Germany.
Gestational duration was based on a second trimester ultrasound. Sweden offers a routine ultrasound examination of pregnant women at 17 -18 postmenstrual weeks [14] , and 97 % of these women agree to the exam. Maternal and pregnancy characteristics are presented in Table 1 . 35 (66) Preterm delivery (GA < 37 w), n ( % ) 46 (89) Very early preterm delivery (GA < 32 w), n ( % ) 27 (53) Extremely early preterm delivery (GA < 28 w), n ( % ) 21 (40) TTTS = twin-to-twin transfusion syndrome, FLOC = fetoscopic laser occlusive coagulation, BMI = body mass index, GA = gestational age, w = weeks.
Fetoscopic laser occlusive coagulation (FLOC)
The median gestational age at FLOC treatment was 21 (range 17 -26) weeks. Three women had been treated with amnioreductions before FLOC and eight underwent amnioreductions after FLOC. Due to an insuffi cient result of the fi rst FLOC, two women were treated twice. After treatment, all women were observed for 2 -3 days, after which they were discharged and referred back to their local obstetric units. No maternal mortality was related to the intervention.
Data collection and outcomes
Data were collected in a hospital-based register. For this purpose, records from maternal, fetal, neonatal and pediatric departments were used. Survival up to 1 year of postnatal age was selected as the primary outcome. Secondary outcomes included the following neonatal data and diagnoses: Apgar score < 7 at 5 min, birth weight and standard deviation scores for birth weight (BW-SDS), birth length, birth head circumference, respiratory distress syndrome (RDS), persistent pulmonary hypertension (PPHN), need for any mechanical ventilation, treatment for patent ductus arteriosus (PDA), culture-proven septicemia, a diagnosis of structural cardiac disease, renal failure, necrotizing enterocolitis (NEC, Bell ' s stages I-III), severe brain injury (defi ned as intraventricular hemorrhage ≥ grade 3 and/or cystic periventricular leukomalacia), bronchopulmonary dysplasia (BPD, defi ned as a need for supplemental oxygen at 36 weeks of postmenstrual age) and severe retinopathy of prematurity (ROP ≥ grade 3). Using ultrasound and/or magnetic resonance tomography, brain imaging was performed on all very preterm infants (gestational age < 32 weeks) and in infants with symptoms of neurological disease (recurrent apnea, seizures, changes in tone). ROP screening was performed in all preterm infants of < 32 weeks of gestational age according to national guidelines [18] .
All women submitted written informed consent for data acquisition and the study protocol was approved by the regional ethics review board in Stockholm.
Statistics
Data are presented as numbers and proportions ( % ) or median (range) values. In order to study differences between groups, the χ 2 -test was used for categorical variables or proportions and the Student ' s t-test or Mann-Whitney U-test was used for continuous variables. Comparing donor and recipient twins χ 2 , paired t-test or Wilcoxon ' s signed ranks test was used, according to Mc Nemar [27] . Linear regression was used to test for associations between maternal and obstetric characteristics and infant survival. A P-value of < 0.05 was considered statistically signifi cant. For statistical analyses, we used PASW Statistics 19 (SPSS Inc., Chicago, IL, USA).
Results
Within the study cohort, there were two dichorionic triamnionic triplet gestations. As the outcome for triplets is known to differ signifi cantly from that for twins [6] , these pregnancies were not included in the analyses. One of the triplet gestations resulted in the survival of one dichorionic triplet, but with double fetal demise of the monochorionic triplets treated with FLOC. In the other triplet gestation, complicated by TTTS and treated with FLOC, all the triplets survived.
Survival
The TTTS cohort treated with FLOC consisted of 142 fetuses, of which 87 (61 % ) were liveborn; 65 (46 % ) of these infants survived to 1 year of postnatal age (Figure 1 ) . In half the number of non-survivors (n = 41) fetal demise occurred within a week after FLOC. Among the fetuses who died, 22 [54 % (10 donors and 12 recipients)] died before 22 weeks and 19 [46 % (12 donors and seven recipients)] died after 22 weeks of gestation.
Eighteen pregnancies (25 % ) ended in spontaneous (n = 16) or induced abortion (n = 2). In 32 pregnancies (45 % ) labor started spontaneously with contractions or rupture of membranes, and in six pregnancies (8 % ) delivery started with vaginal bleeding. In the remaining 15 pregnancies (22 % ), delivery was performed by cesarean section before labor.
Among all the pregnancies treated with FLOC (n = 71), 53 (75 % ) women delivered at least one liveborn twin. In pregnancies lasting longer than 22 weeks (n = 57), at least one in 53 twins were liveborn (93 % ). The mode of delivery in these pregnancies was vaginal in 18 (34 % ), elective C-section in 5 (9 % ) and emergency C-section in 30 (57 % ). The rate of liveborn donors was 41/71 (58 % ) and of recipients 46/71 (65 % , P = 0.36). After fetal demise of the donor twin, the rate of liveborn recipients declined to 41 % . Among the liveborn infants, 1-year survival was 29/41 (71 % ) for donors and 36/46 (78 % ) for recipients (P = 0.12). In pregnancies ending with two liveborn infants, both survived to 1 year in 21/34 (62 % ) cases.
The median gestational age at birth for liveborn infants was 31 (23 -40) weeks. As anticipated, there was a strong association between gestational age at birth and survival. No TTTS infant delivered before 25 completed gestational weeks survived the fi rst week but, if delivery occurred after 28 weeks, 88 % of donors and 96 % of recipients were still alive at 1 year. Total infant survival according to gestational age is presented in Table 2 .
Overall, there were no signifi cant correlations between infant survival and maternal characteristics (age, parity, fi rst trimester BMI and smoking) or infant gender. The proportion of liveborn infants did not differ between Quintero stages I -II (61 % ) and III -IV (61 % ). In addition, infant survival did not correlate to gestational age at FLOC [median 21 (range 17 -26) weeks].
Neonatal anthropometry and morbidity
As expected, donors had a signifi cantly lower birth weight, were shorter and had smaller head circumference than recipients (P < 0.01 for all comparisons). Neonatal morbidity was high overall but there were no statistical differences between donors and recipients (Table 3 ) . Fetal echocardiography was not routinely assessed by a specialist in fetal and pediatric cardiology. Referral to a pediatric cardiology department was made in special cases when this was considered necessary either before or after birth. Fetal myocardial hypertrophy was detected with ultrasound in 19 of the recipients, mostly presented as atrioventricular valve regurgitation and/or biventricular hypertrophy. Two of the donor fetuses were described as showing signs of cardiac dysfunction, and one also showed a valvular pulmonary stenosis. In the recipient group, there were two reported cases of obstructions of right ventricular outfl ow tract. At neonatal follow-up, one of these fetuses was diagnosed with a mild valvular pulmonary stenosis and the other with bilateral stenoses of the pulmonary branches. Five infants, all recipients, were diagnosed with pulmonary hypertension (PPHN). Six twin pairs showed a within-pair hemoglobin difference exceeding 100 g/L indicating a possible twin anemia-polycythemia sequence (TAPS) [23] . One recipient underwent hemodilution and all six donors in these twin-pairs were treated with blood transfusions.
There were two donors and four recipients with suspect NEC (Bell ' s stage I) and one donor and recipient with defi nite NEC (Bell ' s stage II). Of fi ve donors with renal insuffi ciency, one needed peritoneal dialysis for 3 days during neonatal hospital stay. Finally, a gangrenous lower limb of one recipient twin was amputated shortly after birth. 
Discussion
In this cohort of laser-treated TTTS gestations in Sweden from October 2001 to July 2010, there was 75 % fetal survival of at least one twin, and in pregnancies lasting longer than 22 weeks at least one twin was liveborn in 93 % of cases. The risk of fetal or infant death did not differ signifi cantly between donors and recipients. Finally, neonatal morbidity was found to be high, exceeding that of the general neonatal population of a similar gestational age. An important fi nding of this study was the relationship between TTTS and extremely low gestational age, predicting very poor outcome. Among 16 liveborn twins delivered at gestational weeks 23 -26, only two (12 % ) survived to 1 year of age (both were recipients born at 25 completed gestational weeks). In a recently published population-based Swedish report, the general 1-year survival of all infants born at 22 -26 weeks of gestation was 70 % [9] . Accordingly, there is a large difference in infant survival between TTTS infants and other extremely preterm infants, most likely refl ecting a high vulnerability due to distressed hemodynamics in extremely preterm TTTS infants. As a consequence, TTTS infants should preferably not be delivered extremely preterm. However, early preterm delivery is usually unavoidable because of a highly aggressive TTTS, continued placental transfusions due to unsuccessful laser coagulation or spontaneous start of labor.
Considering the poor infant survival rate among extremely preterm TTTS infants, it is questionable whether assessment of the effectiveness of FLOC can be based on rates of perinatal survival alone. While some studies provide information only on whether the twins were born alive or not [13, 29] , our data clearly show that this is insuffi cient and that survival through the fi rst year of life provides a more complete picture.
As opposed to a smaller proportion of preterm infants in the general neonatal population in Sweden [1, 9] , almost half (40/87 = 46 % ) of all liveborn TTTS infants needed support with mechanical ventilation. The rate of mechanical ventilation in moderately preterm (GA = 30 -34 weeks) TTTS twins was 20 % in donors and 27 % in recipients. In a contemporary Swedish national cohort of preterm infants with a similar gestational age, Altman et al. reported a mechanical ventilation rate of 5.5 % [1] . In extremely preterm infants born in Sweden at 25 -26 gestational weeks, mechanical ventilation was needed in 80 % [8] . Also at this extremely low gestational age, we found higher rates (89 -91 % ) of mechanical ventilation in TTTS twins. The higher rates of mechanical ventilation in TTTS infants is most likely a result of long-term cardiac stress and exposure to high plasma concentrations of vasoconstrictors [2] , which will counteract the necessary pulmonary circulatory transition at birth and increase the risk of persistent pulmonary hypertension of the newborn (PPHN). PPHN was reported in recipients (11 % ), but this could be an underestimation, as echocardiographic assessments were not systematically performed in all infants. A recent study of non-laser-treated TTTS neonates showed high systemic blood pressure in recipients in the fi rst hours after birth, although prevalences of PPHN were not reported [28] .
We found no signifi cant differences in major neonatal morbidities between donors and recipients. This could be due to our relatively small sample and limitations in power refl ecting the low rate of Swedish births, but it could also show that there are no major morbidity differences, as has been shown in other studies [20, 24] . Another limitation is the lack of prospective fetal echocardiographies performed by a cardiologist in all pregnancies, even though pediatric echocardiographies after birth were well reported in the records.
One recipient was born with an ischemic lower limb. Ischemic limbs have sporadically been reported in recipient fetuses and are thought to be a result of polycythemia and hyperviscosity [22] .
Considering the high fetal and neonatal morbidity, prospective long-term follow-up programs need to be an integral part of the management of TTTS patients. In addition to direct injury to the developing human, adverse programming of the cardiovascular system may result. Stiffer arteries [11] and elevated blood pressure [15] have been reported in older children exposed to TTTS in utero . We have also previously shown that there is still a signifi cant difference in diastolic myocardial function between recipients and donors at 10 years of age [16] . The twins included in our previous studies were born before the introduction of FLOC. It is still not certain whether FLOC can increase fetal and infant survival and prevent longterm cardiovascular compromise. Similarly, follow-up studies on neurodevelopmental, cognitive and behavioral status after early childhood [3, 12, 17, 26] are warranted in order to fully understand the fi nal outcome of TTTS and FLOC. We have initiated a neurodevelopmental follow-up study but as of today, there are no results to present.
Given the rareness of TTTS, we consider centralization of treatment and care to be crucial in order to improve outcome. In our study, we have included all referred cases since the start of FLOC for TTTS in Sweden in 2001. It is important to note that introduction of a new treatment is associated with a learning curve. Over the past decade, 1-year survival of at least one twin increased from 60 % (2001 -2008) to 68 % (2009 -2010) .
The strengths of this study were the population-based approach and the 100 % follow-up rate to 1 year of postnatal age. Limitations include the relatively small number of treated TTTS pregnancies refl ecting low Swedish birth rates and, at least in the beginning of the study period, low referral rates. However, during the later period of the study, there have been an increasing number of referrals to our center for fetal medicine, probably due to a better awareness of both TTTS and treatment modalities.
Conclusions
In Sweden, the rate of survival of at least one twin after the introduction of FLOC was high and comparable to corresponding data of other international centers. Infant survival did not correlate to gestational age at FLOC. The prevalence of major neonatal morbidity in liveborns was similar in recipients and donors. No TTTS infant delivered before 25 completed gestational weeks survived the fi rst neonatal week.
